Staff members work at the High Energy Photon Source (HEPS) in Beijing, capital of China, June 30, 2024. Upon the completion of the vacuum circuit of its storage ring, the HEPS has entered the joint test stage on Monday. The HEPS is a major science infrastructure project built by the Institute of High Energy Physics under the Chinese Academy of Sciences. (Xinhua/Jin Liwang)
An aerial drone photo taken on Dec. 11, 2023 shows a view of the High Energy Photon Source (HEPS) in Beijing, capital of China. Upon the completion of the vacuum circuit of its storage ring, the HEPS has entered the joint test stage on Monday. The HEPS is a major science infrastructure project built by the Institute of High Energy Physics under the Chinese Academy of Sciences. (Xinhua/Jin Liwang)
Staff members work at the High Energy Photon Source (HEPS) in Beijing, capital of China, June 30, 2024. Upon the completion of the vacuum circuit of its storage ring, the HEPS has entered the joint test stage on Monday. The HEPS is a major science infrastructure project built by the Institute of High Energy Physics under the Chinese Academy of Sciences. (Xinhua/Jin Liwang)
This photo taken on June 30, 2024 shows the storage ring of the High Energy Photon Source (HEPS) in Beijing, capital of China. Upon the completion of the vacuum circuit of its storage ring, the HEPS has entered the joint test stage on Monday. The HEPS is a major science infrastructure project built by the Institute of High Energy Physics under the Chinese Academy of Sciences. (Xinhua/Jin Liwang)
China's High Energy Photon Source (HEPS) project moved one step closer to reality with approval of the HEPS Feasibility Study Report by the National Development and Reform Commission. HEPS will have a beam energy of 6 GeV and an ultra-low emittance ring-based synchrotron radiation light source, allowing China to join an elite global group of high energy synchrotron radiation light sources. It will offer strong support for research fields related to domestic needs and lead to revolutionary innovation in various industries.
Research groups led by Prof. YANG Huangtian from SINH and collaborators found that intramyocardial injection of human embryonic stem cell-derived epicardial cells at the acute phase of myocardial infarction ameliorates functional worsening and scar formation in mouse and swine hearts, which provided a new therapeutic approach for infarcted hearts.
86-10-68597521 (day)
86-10-68597289 (night)
86-10-68511095 (day)
86-10-68512458 (night)
cas_en@cas.cn
52 Sanlihe Rd., Xicheng District,
Beijing, China (100864)
Copyright © 2002 - Chinese Academy of Sciences
